The ATS partners with individuals, industry, and non-profit organizations, pooling resources to maximize the number of high-impact projects that can be funded. A guiding principle of the ATS Research Program is to collaborate with other medical, research, clinical, professional, corporate, patient, and non-profit organizations that are focused on the diagnosis, understanding, and treatment of lung disease.
Special thanks to our partners funding a research grant starting in 2019!
Our research partners sharing research priorities and funding responsibilities are:
Aerocrine, Inc.
Alliance for Academic Internal Medicine
Alpha-1 Foundation
American Lung Association
American Lung Association of Hawaii
American Lung Association of Oregon
American Lung Association of the Mountain Pacific
American Society of Transplantation
ARDS Foundation*
Association of Specialty Professors
Asthma and Allergy Foundation of America
ATS Foundation Tobacco-Dependence Research Fund
Boehringer-Ingelheim Pharmaceuticals, Inc.
Breathe California of Los Angeles
Children’s Interstitial Lung Disease Foundation
Coalition for Pulmonary Fibrosis
COPD Foundation*
Cystic Fibrosis Foundation*
Emphysema Fighting for Our Right to Survive
Foundation for Sarcoidosis Research*
Genentech
Hermansky-Pudlak Syndrome Network*
The LAM Foundation*
LAM Treatment Alliance
LUNGevity Foundation
Mallinckrodt Pharmaceuticals, Inc.
Merck, Inc.
The Nathan Cummings Foundation
Pfizer, Inc.
Primary Ciliary Dyskinesia (PCD) Foundation*
Pulmonary Fibrosis Foundation
Pulmonary Hypertension Association
ResMed
Respiratory Health Association of Metropolitan Chicago
Respironics Foundation
Sarcoidosis Research Institute
Scleroderma Foundation*
Sepsis Alliance
Veterans Administration
Interested in becoming a Research Program Partner?
Email researchprogram@thoracic.org for more information.
* Current members of the ATS Public Advisory Roundtable (PAR)
For more information about ATS PAR, please click here.
